QUANTUM GENOMICS SAS-REGR (ALQGC.PA)
FR0011648971 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.55M | 10.40M | 8.54M | 22.15M | 6.16M | |||
| Cash Equivalents | 0.00 | 0.00 | 5.01M | 5.00M | 5.00M | |||
| Marketable Securities | N/A | N/A | 257.00K | 285.00K | 204.00K | |||
| Receivables | 119.18K | 12.90M | 3.57M | 3.85M | 2.01M | |||
| Inventories | N/A | 0.00 | 0.00 | 1.75M | 332.97K | |||
| Other Current Assets | 20.68K | 93.94K | 4.24M | 750.68K | 719.60K | |||
| Total Current Assets | 3.69M | 23.40M | 21.37M | 33.50M | 14.22M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.89K | 22.95K | 30.17K | 26.54K | 27.21K | |||
| Investments And Advances | 11.00K | 32.31K | 32.31K | 32.31K | 37.88K | |||
| Intangibles | 0.00 | 0.00 | 536.67K | 760.00K | 360.00K | |||
| Other Non-Current Assets | 40.63K | 206.69K | 617.39K | 635.16K | 459.20K | |||
| Total Non-Current Assets | 59.52K | 261.95K | 1.22M | 1.45M | 884.29K | |||
| TOTAL ASSETS | 3.75M | 23.66M | 22.59M | 34.95M | 15.11M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 530.00 | 2.00K | 2.55K | 1.87K | 1.38K | |||
| Current Portion Of LT Debt. | 755.98K | 2.42M | 2.72M | 385.00K | 337.00K | |||
| Accrued Expenses | 270.17K | 696.10K | 614.44K | 546.45K | 489.56K | |||
| Accounts Payable | 272.22K | 16.01M | 6.80M | 6.04M | 3.37M | |||
| Other Current Liabilities | 50.88K | 271.15K | 108.21K | 60.56K | 90.60K | |||
| Total Current Liabilities | 1.35M | 19.39M | 10.24M | 6.64M | 3.95M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.96M | 616.31K | 283.69K | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 1.43K | 472.76K | 452.26K | 294.24K | |||
| Total Non-Current Liabilities | 1.96M | 617.75K | 756.45K | 452.26K | 294.24K | |||
| TOTAL LIABILITIES | 3.31M | 20.01M | 11.00M | 7.10M | 4.24M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -28.11M | -24.93M | -16.46M | -11.32M | -8.90M | |||
| Additional Paid In Capital | 14.61M | 14.61M | 16.91M | 27.77M | 11.85M | |||
| Common Shares | 13.94M | 13.94M | 10.97M | 10.68M | 7.22M | |||
| Other Shareholders' Equity | N/A | 40.00K | 160.00K | 720.01K | 692.50K | |||
| Shares Outstanding | 34.85M | 34.85M | 27.44M | 26.71M | 18.06M | |||
| Tangible Book Value per Share | 0.01 | 0.10 | 0.40 | 1.01 | 0.58 | |||
| Total Shareholders' Equity | 436.66K | 3.65M | 11.59M | 27.86M | 10.86M | |||
| TOTAL LIABILITIES AND EQUITY | 3.75M | 23.66M | 22.59M | 34.95M | 15.11M | |||
| Statistics | ||||||||
| Debt/Equity | 4.49 | 0.17 | 0.02 | N/A | N/A | |||
| Current Ratio | 2.73 | 1.21 | 2.09 | 5.04 | 3.60 | |||
| Return On Assets (ROA) | -84.63% | -105.40% | -73.30% | -33.01% | -60.10% | |||
| Return On Equity (ROE) | -726.18% | -683.61% | -142.90% | -41.42% | -83.57% | |||
All data in EUR , ROIC based on taxRate of 0.27